| Literature DB >> 28773444 |
Arianna Di Lorenzo1, Nora Bloise2, Silvia Meneghini3, Antoni Sureda4, Gian Carlo Tenore5, Livia Visai6,7, Carla Renata Arciola8,9, Maria Daglia10.
Abstract
Biomaterials releasing bactericides have currently become tools for thwarting medical device-associated infections. The ideal anti-infective biomaterial must counteract infection while safeguarding eukaryotic cell integrity. Red wine is a widely consumed beverage to which many biological properties are ascribed, including protective effects against oral infections and related bone (osteoarthritis, osteomyelitis, periprosthetic joint infections) and cardiovascular diseases. In this study, fifteen red wine samples derived from grapes native to the Oltrepò Pavese region (Italy), obtained from the winemaking processes of "Bonarda dell'Oltrepò Pavese" red wine, were analyzed alongside three samples obtained from marc pressing. Total polyphenol and monomeric anthocyanin contents were determined and metabolite profiling was conducted by means of a chromatographic analysis. Antibacterial activity of wine samples was evaluated against Streptococcus mutans, responsible for dental caries, Streptococcus salivarius, and Streptococcus pyogenes, two oral bacterial pathogens. Results highlighted the winemaking stages in which samples exhibit the highest content of polyphenols and the greatest antibacterial activity. Considering the global need for new weapons against bacterial infections and alternatives to conventional antibiotics, as well as the favorable bioactivities of polyphenols, results point to red wine as a source of antibacterial substances for developing new anti-infective biomaterials and coatings for biomedical devices.Entities:
Keywords: anti-infective biomaterials; metabolite profiling; polyphenols; red wine; winemaking process
Year: 2016 PMID: 28773444 PMCID: PMC5503068 DOI: 10.3390/ma9050316
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
List of wine samples, their collection date, step of winemaking process and abbreviation used in this paper.
| Wine Sample | Collection Date | Winemaking Step | Abbreviation |
|---|---|---|---|
| Croatina | 30 September 2015 | Grape crushing, addition of yeast and K2S2O5 | CR1 |
| Croatina | 2 October 2015 | Alcoholic fermentation | CR2 |
| Croatina | 6 October 2015 | Alcoholic fermentation | CR3 |
| Croatina | 8 October 2015 | Malolactic fermentation | CR4 |
| Croatina | 12 October 2015 | Malolactic fermentation | CR5 |
| Croatina | 19 October 2015 | Malolactic fermentation | CR6 |
| Croatina | 26 October 2015 | Malolactic fermentation | CR7 |
| Croatina | 27 October 2015 | Malolactic fermentation | CR8 |
| Barbera | 27 October 2015 | Wine used to dilute Croatina | BA |
| Croatina + Barbera before SO2 addition | 27 October 2015 | Addition of Barbera to obtain Bonarda wine | CB1 |
| Croatina + Barbera after SO2 addition | 27 October 2015 | SO2 addition | CB2 |
| Bonarda wine (end of fermentation) | 30 October 2015 | End of fermentation | BO |
| Croatina Torchiato | 8 October 2015 | Marc pressing | CT1 |
| Croatina Torchiato | 12 October 2015 | Fermentation | CT2 |
| Croatina Torchiato | 19 October 2015 | Fermentation | CT3 |
Figure 1Total polyphenol content of the 15 wine samples by Folin-Ciocalteau’s assay. Data (mg/L GAE) are expressed as the mean ± SD (n = 3); different letters indicate statistically significant differences (p < 0.05) between samples.
Figure 2Total monomeric anthocyanin content of the 15 wine samples obtained by pH-differential method assay. Data (mg/L CGE) are expressed as the mean ± SD (n = 3); different letters indicate statistically significant differences (p < 0.05) between samples.
Chromatographic behavior, MS and MSn data of the compounds identified in the 15 wine samples.
| Peak Number | Retention Time (RT) (min) | HPLC-ESI-MSn (% of Base Peak) | Proposed Structure | ||
|---|---|---|---|---|---|
| 1 | 12.0 | 203, 214 | 191 | 111 (100) | citric acid |
| 2 | 28.0 | 221, 269 | 169 | 125 (100) | gallic acid (a) |
| 3 | 35.4 | 214, 245, 286 | 493 | 331 (100) | laricitrin-hexoside (a) |
| 15 | 74.9 | 214, 233, 278 | 447 | 401 (100), 285 (100) | kaempferol-hexoside |
| 27 | 118.3 | 226, 268, 328 | 479 | 316 (100), 317 (30) | myricetin-hexoside |
| 32 | 121.8 | 226, 268, 285 | 463 | 301 (100) | quercetin-hexoside (b) |
| 35 | 123.8 | 226, 312, 348 | 507 | 344 (100), 345 (50) | syringetin-hexoside (b) |
| 39 | 126.1 | 226, 255, 349 | 477 | 301 (100) | quercetin-glucuronide |
| 4 | 36.4 | 207, 269 | 609 | 441 (100), 423 (85), 305 (35) | gallocatechin derivative |
| 7 | 48.0 | 207, 275 | 305 | 179 (100), 221 (80), 219 (80), 261 (70) | gallocatechin (c), (d) |
| 12 | 69.0 | 224, 230, 279 | 289 | 245 (100), 205 (40), 179 (20) | catechin |
| 20 | 85.8 | 228, 279 | 289 | 246 (100), 205 (40), 179 (10) | epicatechin (c), (d) |
| 5 | 39.7 | 219, 278 | 865 | 695 (100), 577 (40), 289 (20), 407 (10) | procyanidin trimer |
| 6 | 44.9 | 218, 270 | 331 | 169 (100) | galloylglucose (a), (c), (e) |
| 9 | 62.6 | 279 | 577 | 425 (100), 407 (40), 289 (20) | procyanidin dimer |
| 11 | 67.5 | 224, 278 | 577 | 425 (100), 407 (60), 289 (20) | procyanidin dimer |
| 13 | 69.6 | 224, 279 | 865 | 695 (100), 577 (80), 407 (25), 298 (20) | procyanidin trimer |
| 16 | 75.5 | 278 | 865 | 695 (100), 577 (80), 407 (25), 298 (20) | procyanidin trimer |
| 18 | 79.6 | 221, 278 | 577 | 425 (100), 407 (50), 289 (15) | procyanidin dimer |
| 22 | 89.8 | 223, 280 | 865 | 695 (100), 577 (40), 793 (40) | procyanidin trimer (f) |
| 8 | 54.5 | 223, 276 | 595 | 443 (100), 425 (80) | cyanidin-6- |
| 10 | 64.0 | 215, 222, 279 | 465 | 303 (100) | delphinidin-hexoside |
| 14 | 74.0 | 206, 279 | 449 | 287 (100) | cyanidin-hexoside |
| 17 | 79.4 | 205, 214, 279 | 479 | 317 (100) | petunidin-hexoside |
| 19 | 81.1 | 226, 280 | 463 | 301 (100) | peonidin-hexoside |
| 21 | 88.0 | 223, 279 | 493 | 331 (100) | malvidin-hexoside |
| 23 | 93.0 | 224, 280 | 507 | 303 (100) | delphinidin-3-acetylhexoside (h), (i) |
| 24 | 104.0 | 206, 219, 280 | 521 | 317 (100) | petunidin-3-acetylhexoside |
| 25 | 107.5 | 204, 215, 281 | 517 | 355 (100) | malvidin-3-glucosylacetaldehyde |
| 26 | 111.0 | 224, 280 | 535 | 331 (100) | malvinidin-3-acetylhexoside |
| 29 | 120.0 | 233, 280 | 809 | 357 (100), 519 (80), 547 (20) | malvidin-3- |
| 30 | 121.1 | 232, 280 | 561 | 399 (100) | malvidin-3-glucosidepiruvate |
| 31 | 121.3 | 230, 283 | 625 | 317 (100) | petunidin-3-(6- |
| 33 | 122.0 | 230, 280 | 609 | 447 (100), 301 (70) | peonidin-3-O-(C6-coumaroyl)-hexoside (l) |
| 34 | 122.2 | 232, 282 | 639 | 331 (100) | malvidin-3-coumaroylhexoside |
| 36 | 124.0 | 227, 280 | 707 | 399 (100) | malvidin-3- |
| 37 | 124.5 | 227, 280 | 707 | 399 (100) | carboxypyrano-malvidin-3-coumaroylglucoside (d) |
| 38 | 125.9 | 226, 355 | 479 | 303 (100) | delphinidin-glucuronide |
| 28 | 119.6 | - | 389 | 227 (100) | resveratrol-hexoside (b) |
(a) Compound not revealed in CR1 sample; (b) Compound not revealed in BA sample; (c) Compound not revealed in CR1 and CR2 samples; (d) Compound not revealed from CT1 to CT3 sample; (e) Compound not revealed in CT3 sample; (f) Compound not revealed from CR1 to CR6 sample; (g) Anthocyanins were revealed in positive ionization mode; (h) Compound revealed in trace from CR1 to CR6 sample; (i) Compound not revealed in CT1 and CT2 samples; (l) Compound revealed in trace in all samples.
Figure 3Chromatographic profile of CR5 sample acquired at 280 nm.
Presence (+) or absence (-) of the identified flavonols, flavan-3-ols, tannins, stilbenoids, benzoic and organic acids in the 15 wine samples.
| laricitrin-hexoside | - | + | + | + | + | + | + | + | + |
| kaempferol-hexoside | + | + | + | + | + | + | + | + | + |
| myricetin-hexoside | + | + | + | + | + | + | + | + | + |
| quercetin-hexoside | + | + | + | - | + | + | + | + | + |
| quercetin-glucuronide | + | + | + | + | + | + | + | + | + |
| syringetin-hexoside | + | + | + | - | + | + | + | + | + |
| gallocatechin derivative | + | + | + | + | + | + | + | + | + |
| gallocatechin | - | - | + | + | + | + | - | - | - |
| catechin | + | + | + | + | + | + | + | + | + |
| epicatechin | - | - | + | + | + | + | - | - | - |
| galloylglucose | - | - | + | - | + | + | + | + | - |
| procyanidin dimer | + | + | + | + | + | + | + | + | + |
| procyanidin dimer | + | + | + | + | + | + | + | + | + |
| procyanidin dimer | + | + | + | + | + | + | + | + | + |
| procyanidin trimer | + | + | + | + | + | + | + | + | + |
| procyanidin trimer | + | + | + | + | + | + | + | + | + |
| procyanidin trimer | + | + | + | + | + | + | + | + | + |
| procyanidin trimer | - | - | - (CR3-CR6) | + | + | + | + | + | + |
| resveratrol-hexoside | + | + | + | - | + | + | + | + | + |
| citric acid | + | + | + | + | + | + | + | + | + |
| gallic acid | - | + | + | + | + | + | + | + | + |
Presence (+) or absence (-) of the identified anthocyanins in the 15 wine samples.
| Anthocyanin | CR1 | CR2 | CR3-CR8 | BA | CB1-CB2 | BO | CT1 | CT2 | CT3 |
|---|---|---|---|---|---|---|---|---|---|
| cyanidin-6- | + | + | + | + | + | + | + | + | + |
| cyanidin-hexoside | + | + | + | + | + | + | + | + | + |
| delphinidin-hexoside | + | + | + | + | + | + | + | + | + |
| delphinidin-3-acetylhexoside | in trace | in trace | in trace from CR3 to CR6 | + | + | + | - | - | + |
| delphinidin-glucuronide | + | + | + | + | + | + | + | + | + |
| petunidin-hexoside | + | + | + | + | + | + | + | + | + |
| petunidin-3-acetylhexoside | + | + | + | + | + | + | + | + | + |
| petunidin-3-(6- | in trace | ||||||||
| peonidin-hexoside | + | + | + | + | + | + | + | + | + |
| peonidin-3-(C6-coumaroyl)-hexoside | in trace | ||||||||
| malvidin-hexoside | + | + | + | + | + | + | + | + | + |
| malvidin-3-glucosylacetaldehyde | + | + | + | + | + | + | + | + | + |
| malvidin-3-acetylhexoside | + | + | + | + | + | + | + | + | + |
| malvidin-3- | + | + | + | + | + | + | + | + | + |
| malvidin-3-glucosidepiruvate | + | + | + | + | + | + | + | + | + |
| malvidin-3- | + | + | + | + | + | + | + | + | + |
| malvidin-3-coumaroylhexoside | + | + | + | + | + | + | + | + | + |
| carboxypyrano-malvidin-3-courmaroylglucoside | + | + | + | + | + | + | - | - | - |
Minimal inhibitory concentration (MIC) of each type of dealcoholized wine against two oral Streptococci and S. pyogenes. Concentration necessary to inhibit 100% of the microbial growth in vitro, expressed in v/v % solution.
| Delacoholized Wine | |||
|---|---|---|---|
| CR1 | 60 | 60 | 60 |
| CR2 | 40 | 40 | 40 |
| CR3 | 20 | 20 | 40 |
| CR4 | 20 | 20 | 40 |
| CR5 | 20 | 20 | 40 |
| CR6 | 20 | 20 | 40 |
| CR7 | 20 | 20 | 40 |
| CR8 | 20 | 20 | 40 |
| BA | 40 | 40 | 40 |
| CB1 | 20 | 20 | 40 |
| CB2 | 20 | 20 | 40 |
| BO | 20 | 20 | 20 |
| CT1 | 20 | 20 | 20 |
| CT2 | 20 | 20 | 20 |
| CT3 | 20 | 20 | 20 |